BR9701404A - Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol - Google Patents

Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol

Info

Publication number
BR9701404A
BR9701404A BR9701404A BR9701404A BR9701404A BR 9701404 A BR9701404 A BR 9701404A BR 9701404 A BR9701404 A BR 9701404A BR 9701404 A BR9701404 A BR 9701404A BR 9701404 A BR9701404 A BR 9701404A
Authority
BR
Brazil
Prior art keywords
trisdehydro
cholecal
ciferol
dihydroxy
derivatives
Prior art date
Application number
BR9701404A
Other languages
English (en)
Inventor
Jerome Anthony Lacobelli
Milan Radoje Uskokovic
Bernard Michael Hennessy
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9701404A publication Critical patent/BR9701404A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)
  • Furan Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
BR9701404A 1996-03-21 1997-03-20 Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol BR9701404A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1380996P 1996-03-21 1996-03-21

Publications (1)

Publication Number Publication Date
BR9701404A true BR9701404A (pt) 1998-11-03

Family

ID=21761865

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9701404A BR9701404A (pt) 1996-03-21 1997-03-20 Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol

Country Status (30)

Country Link
EP (1) EP0796843B1 (pt)
JP (1) JP2801587B2 (pt)
KR (1) KR100240541B1 (pt)
CN (1) CN1110477C (pt)
AR (1) AR006315A1 (pt)
AT (1) ATE240941T1 (pt)
AU (1) AU708679B2 (pt)
BR (1) BR9701404A (pt)
CA (1) CA2199893C (pt)
CO (1) CO4820396A1 (pt)
CZ (1) CZ85897A3 (pt)
DE (1) DE69722064T2 (pt)
DK (1) DK0796843T3 (pt)
ES (1) ES2198512T3 (pt)
HR (1) HRP970162A2 (pt)
HU (1) HUP9700609A3 (pt)
ID (1) ID16285A (pt)
IL (1) IL120469A0 (pt)
MA (1) MA26423A1 (pt)
MX (1) MX9702139A (pt)
NO (1) NO971217L (pt)
NZ (1) NZ314424A (pt)
PE (1) PE42998A1 (pt)
PL (1) PL319070A1 (pt)
PT (1) PT796843E (pt)
SG (1) SG70589A1 (pt)
TR (1) TR199700219A2 (pt)
TW (1) TW444001B (pt)
YU (1) YU10397A (pt)
ZA (1) ZA972302B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
KR101285720B1 (ko) * 2012-03-02 2013-07-19 주식회사 유니크메디케어 여드름 개선용 조성물
KR102493627B1 (ko) 2015-11-26 2023-01-31 코웨이 주식회사 호르데닌을 유효성분으로 함유하는 피부암 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
DE69005897D1 (de) * 1989-05-18 1994-02-24 Hoffmann La Roche Dehydrocholecalciferolderivate.

Also Published As

Publication number Publication date
CA2199893C (en) 2008-02-05
PE42998A1 (es) 1998-08-11
DK0796843T3 (da) 2003-09-15
CN1172793A (zh) 1998-02-11
EP0796843A3 (en) 1999-04-14
DE69722064D1 (de) 2003-06-26
DE69722064T2 (de) 2004-04-08
HU9700609D0 (en) 1997-05-28
ZA972302B (en) 1997-09-22
HUP9700609A3 (en) 1999-03-01
KR100240541B1 (ko) 2000-01-15
CO4820396A1 (es) 1999-07-28
TR199700219A3 (tr) 1997-10-21
HRP970162A2 (en) 1998-04-30
MA26423A1 (fr) 2004-12-20
PT796843E (pt) 2003-09-30
TR199700219A2 (xx) 1997-10-21
ID16285A (id) 1997-09-18
CZ85897A3 (cs) 1998-04-15
MX9702139A (es) 1998-04-30
ATE240941T1 (de) 2003-06-15
YU10397A (sh) 1999-07-28
JP2801587B2 (ja) 1998-09-21
TW444001B (en) 2001-07-01
PL319070A1 (en) 1997-09-29
JPH107651A (ja) 1998-01-13
AR006315A1 (es) 1999-08-25
AU708679B2 (en) 1999-08-12
NO971217L (no) 1997-09-22
CA2199893A1 (en) 1997-09-21
NO971217D0 (no) 1997-03-17
KR970065495A (ko) 1997-10-13
NZ314424A (en) 1998-07-28
AU1513597A (en) 1997-09-25
HUP9700609A2 (hu) 1998-07-28
SG70589A1 (en) 2000-02-22
ES2198512T3 (es) 2004-02-01
IL120469A0 (en) 1997-07-13
EP0796843B1 (en) 2003-05-21
CN1110477C (zh) 2003-06-04
EP0796843A2 (en) 1997-09-24

Similar Documents

Publication Publication Date Title
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
PT901474E (pt) Derivados de aril-pirimidina.
PT934320E (pt) Derivados de naftiridina
BR9708386A (pt) Derivados de 6-fenilpiridil-2-amina
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
ATE231847T1 (de) Substituierte 1,2,3,4- tetrahydronaphthalinderivate
FI952424L (fi) 11,21-bisfenyyli-19-norpregaanijohdannaisia
BR9709065A (pt) Derivados de alquilaminobenzotiazole e-benzoxazol
MA26503A1 (fr) Derives de 5'-desoxy-cytidine.
PT922050E (pt) Derivados de 3-descladinose-2,3-anidroeritromicina
PT901488E (pt) Derivados de 2,4-diaminopirimidina
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
PT906279E (pt) Derivados de pirrol
PT931087E (pt) Novos derivados de piranosido
DE69714358D1 (de) 9,10-disubstituierte campothecinderivate mit antitumoraktivität
MA26440A1 (fr) Derives de n-benzylazolium
TR28915A (tr) Naftokinon türevleri.
ATE240941T1 (de) 1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate
BR9708310A (pt) Derivados de 2-tioxotetrahidropirimidin-4-ona
BR9706980A (pt) Derivados de isooxacefem
BR9708948A (pt) 1,3 - Benzodioxois substituídos
BR9510036A (pt) Derivados de 1,3,4-oxadiazina
TR199700927A3 (tr) N-Benzilazolyum türevleri.

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1838 DE 28/03/2006.